Microalbuminuria in risk stratification of non-diabetic hypertesive patients

S Vadimovna Villevalde; Виллевальде Светлана Вадимовна; E Aleksandrovich Tuykhmenev; Тюхменев Евгений Александрович; A Sergeevna Klimenko; Клименко Анна Сергеевна; Y Anatol'evna Pigareva; Пигарева Юлия Анатольевна; Z Davidovna Kobalava; Кобалава Жанна Давидовна

Microalbuminuria in risk stratification of non-diabetic hypertesive patients

Authors: Villevalde SV.¹, Tuykhmenev EA.¹, Klimenko AS.¹, Pigareva YA.¹, Kobalava ZD.¹
Affiliations:
1. People Friendship University of Russia
Issue: No 3 (2011)
Pages: 57-61
Section: Articles
URL: http://journals.rudn.ru/medicine/article/view/3270
Cite item

Abstract
About the authors
References
Statistics

Abstract

Microalbuminuria (MAU) and a reduction in glomerular filtration rate are independent predictors of cardiovascular morbidity and mortality. Aim was to assess the role of MAU in risk stratification of non-diabetic hypertensive patients. The subgroup of patients with MAU was much more likely to show the other signs of subclinical organ damage as compared to patients with left ventricular hypertrophy, carotid abnormalities or increased pulse wave velocity. Thus, MAU is the integral marker of subclinical organ damage.